These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15368321)

  • 1. African-American/White differences in breast carcinoma: p53 alterations and other tumor characteristics.
    Jones BA; Kasl SV; Howe CL; Lachman M; Dubrow R; Curnen MM; Soler-Vila H; Beeghly A; Duan F; Owens P
    Cancer; 2004 Sep; 101(6):1293-301. PubMed ID: 15368321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
    Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
    Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma.
    Porter PL; Lund MJ; Lin MG; Yuan X; Liff JM; Flagg EW; Coates RJ; Eley JW
    Cancer; 2004 Jun; 100(12):2533-42. PubMed ID: 15197793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.
    Stark A; Kapke A; Schultz D; Brown R; Linden M; Raju U
    Breast Cancer Res Treat; 2008 Feb; 107(3):405-14. PubMed ID: 17431759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
    Elledge RM; Clark GM; Chamness GC; Osborne CK
    J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.
    Middleton LP; Amin M; Gwyn K; Theriault R; Sahin A
    Cancer; 2003 Sep; 98(5):1055-60. PubMed ID: 12942575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.
    Tawfik O; Davis K; Kimler BF; Davis MK; Hull S; Fan F; Khan QJ; O'Dea AP; Thomas P
    Ann Clin Lab Sci; 2010; 40(4):315-23. PubMed ID: 20947804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early onset of breast carcinoma in African American women with poor prognostic factors.
    Aziz H; Hussain F; Sohn C; Mediavillo R; Saitta A; Hussain A; Brandys M; Homel P; Rotman M
    Am J Clin Oncol; 1999 Oct; 22(5):436-40. PubMed ID: 10521053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic grade, stage, and survival in breast carcinoma: comparison of African American and Caucasian women.
    Henson DE; Chu KC; Levine PH
    Cancer; 2003 Sep; 98(5):908-17. PubMed ID: 12942556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma HER-2/neu in African American and Hispanic women with breast cancer.
    Wu Y; Khan H; Chillar R; Vadgama JV
    Int J Oncol; 1999 Jun; 14(6):1021-37. PubMed ID: 10339653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
    Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
    Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma.
    Choi DH; Shin DB; Lee MH; Lee DW; Dhandapani D; Carter D; King BL; Haffty BG
    Cancer; 2003 Oct; 98(8):1587-95. PubMed ID: 14534873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 21-Gene recurrence scores: racial differences in testing, scores, treatment, and outcome.
    Lund MJ; Mosunjac M; Davis KM; Gabram-Mendola S; Rizzo M; Bumpers HL; Hearn S; Zelnak A; Styblo T; O'Regan RM
    Cancer; 2012 Feb; 118(3):788-96. PubMed ID: 21720988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of HER-2/NEU receptor of invasive mammary carcinoma between Caucasian and African American patients in the Detroit metropolitan area. Correlation with overall survival and other prognostic factors.
    Al-Abbadi MA; Washington TA; Saleh HA; Tekyi-Mensah SE; Lucas DR; Briston CA
    Breast Cancer Res Treat; 2006 May; 97(1):3-8. PubMed ID: 16432664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial variation in breast tumor promoter methylation in the Carolina Breast Cancer Study.
    Conway K; Edmiston SN; Tse CK; Bryant C; Kuan PF; Hair BY; Parrish EA; May R; Swift-Scanlan T
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):921-30. PubMed ID: 25809865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer.
    Moran MS; Yang Q; Harris LN; Jones B; Tuck DP; Haffty BG
    Cancer; 2008 Nov; 113(9):2565-74. PubMed ID: 18816610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
    Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
    J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race and the prognostic influence of p53 in women with breast cancer.
    Dookeran KA; Dignam JJ; Holloway N; Ferrer K; Sekosan M; McCaskill-Stevens W; Gehlert S
    Ann Surg Oncol; 2012 Jul; 19(7):2334-44. PubMed ID: 22434242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. There is no difference in survival between African-American and white women with breast cancer.
    English WP; Cleveland KE; Barber WH
    Am Surg; 2002 Jun; 68(6):594-7. PubMed ID: 12079146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
    Tan F; Mosunjac M; Adams AL; Adade B; Taye O; Hu Y; Rizzo M; Ofori-Acquah SF
    BMC Cancer; 2014 Sep; 14():715. PubMed ID: 25255861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.